Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries
Authors:
- Jakob ChristensenJCJakob Christensen
- Helga ZoegaHZHelga Zoega
- Maarit K. LeinonenMLMaarit K. Leinonen
- Nils Erik GilhusNGNils Erik Gilhus
- Mika GisslerMGMika Gissler
- Jannicke IglandJIJannicke Igland
- Yuelian SunYSYuelian Sun
- Torbjörn TomsonTTTorbjörn Tomson
- Silje AlvestadSASilje Alvestad
- Marte-Helene BjørkMBMarte-Helene Bjørk
- Julie Werenberg DreierJDJulie Werenberg Dreier
Open Access
- 8 February 2024
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 38, 100849
Abstract
No abstract availableKeywords
Funding Information
- Aarhus University
- Aarhus University Hospital
- Universitetet i Bergen
- Finnish Institute for Health and Welfare
- University of Iceland
This publication has 33 references indexed in Scilit:
- Differential effects of antiepileptic drugs on neonatal outcomesEpilepsy & Behavior, 2012
- Drug use during pregnancy in Sweden – assessed by the Prescribed Drug Register and the Medical Birth RegisterClinical Epidemiology, 2011
- The Nordic Countries as a Cohort for Pharmacoepidemiological ResearchBasic & Clinical Pharmacology & Toxicology, 2010
- Population-based study of antiepileptic drug exposure in utero—Influence on head circumference in newbornsSeizure: European Journal of Epilepsy, 2009
- Affect of Seizures During Gestation on Pregnancy Outcomes in Women With EpilepsyArchives of Neurology, 2009
- 8. How to Impute Interactions, Squares, and other Transformed VariablesSociological Methodology, 2009
- Do Pregnant Women Report Use of Dispensed Medications?Epidemiology, 2001
- A united states national reference for fetal growthObstetrics & Gynecology, 1996
- Teratogenicity of carbamazepine in ratsTeratology, 1990
- WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASEThe Lancet, 1989